LENTIVAX Trademark

Trademark Overview


On Tuesday, November 2, 1999, a trademark application was filed for LENTIVAX with the United States Patent and Trademark Office. The USPTO has given the LENTIVAX trademark a serial number of 75838444. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, April 4, 2001. This trademark is owned by VaxGen, Inc.. The LENTIVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical vaccines for HIV
lentivax

General Information


Serial Number75838444
Word MarkLENTIVAX
Filing DateTuesday, November 2, 1999
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, April 4, 2001
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 11, 2000

Trademark Statements


Goods and ServicesPharmaceutical vaccines for HIV

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVaxGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 940051841

Party NameVaxGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 940051841

Trademark Events


Event DateEvent Description
Tuesday, August 21, 2001ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 3, 2000NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2000PUBLISHED FOR OPPOSITION
Friday, June 9, 2000NOTICE OF PUBLICATION
Monday, February 28, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 24, 2000ASSIGNED TO EXAMINER

Related Keywords


lentivax vaccines pharmaceutical